188 related articles for article (PubMed ID: 10744628)
1. Dopamine transporter proline mutations influence dopamine uptake, cocaine analog recognition, and expression.
Lin Z; Itokawa M; Uhl GR
FASEB J; 2000 Apr; 14(5):715-28. PubMed ID: 10744628
[TBL] [Abstract][Full Text] [Related]
2. Dopamine transporter: transmembrane phenylalanine mutations can selectively influence dopamine uptake and cocaine analog recognition.
Lin Z; Wang W; Kopajtic T; Revay RS; Uhl GR
Mol Pharmacol; 1999 Aug; 56(2):434-47. PubMed ID: 10419565
[TBL] [Abstract][Full Text] [Related]
3. Dopamine transporter tryptophan mutants highlight candidate dopamine- and cocaine-selective domains.
Lin Z; Wang W; Uhl GR
Mol Pharmacol; 2000 Dec; 58(6):1581-92. PubMed ID: 11093799
[TBL] [Abstract][Full Text] [Related]
4. Dopamine transporter transmembrane domain polar mutants: DeltaG and DeltaDeltaG values implicate regions important for transporter functions.
Itokawa M; Lin Z; Cai NS; Wu C; Kitayama S; Wang JB; Uhl GR
Mol Pharmacol; 2000 Jun; 57(6):1093-103. PubMed ID: 10825379
[TBL] [Abstract][Full Text] [Related]
5. Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding.
Kitayama S; Shimada S; Xu H; Markham L; Donovan DM; Uhl GR
Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7782-5. PubMed ID: 1502198
[TBL] [Abstract][Full Text] [Related]
6. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK
J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005
[TBL] [Abstract][Full Text] [Related]
7. Dissociation of high-affinity cocaine analog binding and dopamine uptake inhibition at the dopamine transporter.
Wang W; Sonders MS; Ukairo OT; Scott H; Kloetzel MK; Surratt CK
Mol Pharmacol; 2003 Aug; 64(2):430-9. PubMed ID: 12869648
[TBL] [Abstract][Full Text] [Related]
8. The dopamine transporter carboxyl-terminal tail. Truncation/substitution mutants selectively confer high affinity dopamine uptake while attenuating recognition of the ligand binding domain.
Lee FJ; Pristupa ZB; Ciliax BJ; Levey AI; Niznik HB
J Biol Chem; 1996 Aug; 271(34):20885-94. PubMed ID: 8702845
[TBL] [Abstract][Full Text] [Related]
9. Proline mutations induce negative-dosage effects on uptake velocity of the dopamine transporter.
Lin Z; Uhl GR
J Neurochem; 2005 Jul; 94(1):276-87. PubMed ID: 15953370
[TBL] [Abstract][Full Text] [Related]
10. The role of conserved tryptophan and acidic residues in the human dopamine transporter as characterized by site-directed mutagenesis.
Chen N; Vaughan RA; Reith ME
J Neurochem; 2001 May; 77(4):1116-27. PubMed ID: 11359877
[TBL] [Abstract][Full Text] [Related]
11. Dopamine efflux via wild-type and mutant dopamine transporters: alanine substitution for proline-572 enhances efflux and reduces dependence on extracellular dopamine, sodium and chloride concentrations.
Itokawa M; Lin Z; Uhl GR
Brain Res Mol Brain Res; 2002 Dec; 108(1-2):71-80. PubMed ID: 12480180
[TBL] [Abstract][Full Text] [Related]
12. Dopamine transporter mutants with cocaine resistance and normal dopamine uptake provide targets for cocaine antagonism.
Lin Z; Uhl GR
Mol Pharmacol; 2002 Apr; 61(4):885-91. PubMed ID: 11901228
[TBL] [Abstract][Full Text] [Related]
13. Mutation of Trp84 and Asp313 of the dopamine transporter reveals similar mode of binding interaction for GBR12909 and benztropine as opposed to cocaine.
Chen N; Zhen J; Reith ME
J Neurochem; 2004 May; 89(4):853-64. PubMed ID: 15140185
[TBL] [Abstract][Full Text] [Related]
14. Dopamine transporter mutants selectively enhance MPP+ transport.
Kitayama S; Wang JB; Uhl GR
Synapse; 1993 Sep; 15(1):58-62. PubMed ID: 8310426
[TBL] [Abstract][Full Text] [Related]
15. Identification of intracellular residues in the dopamine transporter critical for regulation of transporter conformation and cocaine binding.
Loland CJ; Grånäs C; Javitch JA; Gether U
J Biol Chem; 2004 Jan; 279(5):3228-38. PubMed ID: 14597628
[TBL] [Abstract][Full Text] [Related]
16. Importance of valine at position 152 for the substrate transport and 2beta-carbomethoxy-3beta-(4-fluorophenyl)tropane binding of dopamine transporter.
Lee SH; Chang MY; Lee KH; Park BS; Lee YS; Chin HR; Lee YS
Mol Pharmacol; 2000 May; 57(5):883-9. PubMed ID: 10779370
[TBL] [Abstract][Full Text] [Related]
17. The uptake inhibitors cocaine and benztropine differentially alter the conformation of the human dopamine transporter.
Reith ME; Berfield JL; Wang LC; Ferrer JV; Javitch JA
J Biol Chem; 2001 Aug; 276(31):29012-8. PubMed ID: 11395483
[TBL] [Abstract][Full Text] [Related]
18. The top 20 dopamine transporter mutants: structure-function relationships and cocaine actions.
Uhl GR; Lin Z
Eur J Pharmacol; 2003 Oct; 479(1-3):71-82. PubMed ID: 14612139
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine-533 of rat dopamine transporter: involvement in interactions with 1-methyl-4-phenylpyridinium and cocaine.
Mitsuhata C; Kitayama S; Morita K; Vandenbergh D; Uhl GR; Dohi T
Brain Res Mol Brain Res; 1998 May; 56(1-2):84-8. PubMed ID: 9602072
[TBL] [Abstract][Full Text] [Related]
20. Substrate transport and cocaine binding of human dopamine transporter is reduced by substitution of carboxyl tail with that of bovine dopamine transporter.
Lee SH; Cho HK; Son H; Lee YS
Neuroreport; 1997 Jul; 8(11):2591-4. PubMed ID: 9261833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
